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a b s t r a c t 
Cardiopulmonary bypass procedures are one of the most common operations and blood oxygenators are 
the centre piece for the heart-lung machines. Blood oxygenators have been tested as entire devices but 
intricate details on the ﬂow ﬁeld inside the oxygenators remain unknown. In this study, a novel method 
is presented to analyse the ﬂow ﬁeld inside oxygenators based on micro Computed Tomography ( μCT) 
scans. Two Hollow Fibre Membrane (HFM) oxygenator prototypes were scanned and three-dimensional 
full scale models that capture the device-speciﬁc ﬁbre distributions are set up for computational ﬂuid 
dynamics analysis. The blood ﬂow through the oxygenator is modelled as a non-Newtonian ﬂuid. The 
results were compared against the ﬂow solution through an ideal ﬁbre distribution and show the impor- 
tance of a uniform distribution of ﬁbres and that the oxygenators analysed are not susceptible to ﬂow 
directionality as mass ﬂow versus area remain the same. However the pressure drop across the oxygena- 
tor is dependent on ﬂow rate and direction. By comparing residence time of blood against the time frame 
to fully saturate blood with oxygen we highlight the potential of this method as design optimisation tool. 
In conclusion, image-based reconstruction is found to be a feasible route to assess oxygenator perfor- 
mance through ﬂow modelling. It offers the possibility to review a product as manufactured rather than 
as designed, which is a valuable insight as a precursor to the approval processes. Finally, the ﬂow analysis 
presented may be extended, at computational cost, to include species transport in further studies. 
© 2017 The Authors. Published by Elsevier Ltd on behalf of IPEM. 
This is an open access article under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
1. Introduction 
According to the National Health Service (NHS [19] ) and Health 
and Safety Executive (HSE [10] ), up to 25,0 0 0 people die of Chronic 
Obstructive Pulmonary Disease (COPD) every year and the disorder 
affects over a million individuals in Great Britain. In addition up to 
400 people develop Acute Respiratory Distress Syndrome (ARDS) 
with a mortality rate of over 50%. Improving treatment techniques 
have a direct social and individual impact in saving lives, increas- 
ing life expectancy and reducing cost to the public health ser- 
vices. Two different methods are clinically approved and are used 
to transfer oxygen into the blood: 
• Mechanical ventilation, mainly controlled by pressure and/or 
volume (Chatburn et al. [4] ), transfers oxygen into the lungs of 
the patient for the gas exchange. Often the ventilation pres- 
sure and oxygen concentration are set very high to overcome 
∗ Corresponding author. 
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the impaired lung function. A potentially resulting barotrauma, 
volutrauma and oxygen toxicity may prevent or slow down the 
lung recovery. 
• Extra Corporeal Membrane Oxygenation (ECMO) is bypassing 
the cardiopulmonary cycle by oxygenating the blood outside 
the patient by pumping blood through a bed of micro-porous 
Hollow Fibres Membranes (HFM). For details on the develop- 
ment of ECMO, the reader is referred to Haworth [8] . 
For the last decade ECMO devices based on HFM prevailed and 
has brought a new branch of studies, where the oxygenator it- 
self is investigated. The oxygenator is one of the centre pieces 
of the ECMO circuit and the development of hollow ﬁbres with 
membranes or micro porous walls is advancing rapidly with novel 
materials and coatings. The effort to optimize the HFM-assembly 
concentrates to reduce the pressure drop across the device, to min- 
imize haemolysis, decrease the priming volume of blood, and in- 
crease biocompatibility and lifetime of HFM oxygenators. 
Computational ﬂuid dynamic (CFD) models are used to study 
blood ﬂow path, heat exchange, pressure drop, stress analysis, 
http://dx.doi.org/10.1016/j.medengphy.2017.06.035 
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mass transfer of oxygen and carbon dioxide, different convection- 
diffusion models, blood stagnation, thrombogenicity, etc. These 
models use either a homogeneous porous media to describe the 
ﬁbre bundle in bulk or a heterogeneous approach to model sin- 
gle ﬁbre arrangements. The rheology is usually implemented as 
Newtonian ﬂow ﬁeld or more realistically described as shear thin- 
ning ﬂuid. Non-Newtonian shear thinning numerical models for 
blood are well known and described by Johnston et al. [11] or 
Marcinkowska-Gapi ´nska et al. [15] . 
For example Gartner et al. [6] and Pelosi et al. [20] use a porous 
media approach to model thrombogenic depositions and study the 
thrombogenic potential of oxygenators. Zhang et al. [25] predict 
blood-gas exchange and pressure drop with a Newtonian ﬂow ﬁeld 
through a porous media. A comparison of different porous me- 
dia models is presented by Khanafer et al. [13] with a set porosity 
(  = 0 . 75 ). Hormes et al. [9] present a novel diffusivity model to 
predict the O 2 and CO 2 mass transfer and partial pressure, which 
is validated by comparing the numerical solution with a purpose 
built oxygenator. The oxygenator and the CFD model use a uniform 
distribution of ﬁbres. 
Commonly the same partial pressure P O 2 is applied at the ﬁbre 
surface for convection and diffusivity. Taskin et al. [23] presented a 
novel model to describe gas exchange as proﬁle on the ﬁbre sur- 
face. The study is comparing a single and multi ﬁbre approach with 
uniform ﬁbre distribution. 
A study by Nagase et al. [18] presented mass transfer correla- 
tions based on the theory for heat transfer across a tube bank and 
concluded that the mass transfer performance of membrane oxy- 
genators is attributable to the hollow ﬁbre arrangement. The lay- 
outs considered are uniformly arranged staggered or squared (in- 
line) ﬁbres. 
An oxygenator cross-section modelled with individual ﬁbres in 
two dimensions is compared to the porous media approach by 
Mazaheri and Ahmadi [16] . To avoid computational costly simu- 
lations of individual ﬁbres, novel porous models are developed to 
integrate the ﬁbre distribution for a better local process mapping 
(Low et al. [14] , Zhang et al. [25] ) and an attempt to “adjust” the 
porosity based on ﬁbre orientation is described by Bhavsar et al. 
[3] . 
But all off these models have been developed with the assump- 
tion of a uniform distribution of ﬁbres either staggered, squared 
or crossed (3D) or simpliﬁed with a porous media approach. Al- 
though a good agreement between numerical predictions and ex- 
perimental results has been reported in the literature by Consolo 
et al. [5] and Pelosi et al. [20] , the porous media approach is in- 
herently unable to capture and characterize the intricate details on 
the ﬂow ﬁeld within the ﬁbre bundles. 
Imaging modalities can be used as a diagnostic tool to investi- 
gate the micro-structural components in an oxygenator and, when 
combined with CFD, can even provide information on the localised 
functional behaviour (ﬂow/oxygenation) of the device. In this paper 
we demonstrate a method for building a full-scale, image-based, 
three-dimensional computational model of a blood oxygenator. All 
individual ﬁbres are reconstructed from the images of a μCT scan 
and CFD is performed using a Non-Newtonian ﬂuid model to in- 
vestigate the local ﬂow ﬁeld inside the device. 
2. Prototypes and methods 
The common method of extra-corporeal oxygenating blood is 
achieved by pumping ambient air or through the core of HFM’s 
whereas the blood is ﬂowing on the outside of the ﬁbres. Molecu- 
lar diffusion increases the oxygen level in the red blood cells and 
removes carbon dioxide from the venous blood. 
Fig. 1. Image of an oxygenator prototype (SRD3083), courtesy of Haemair Ltd. For 
this experiment, blood ﬂows from the inlet A to the outlet B. 
2.1. Prototypes 
Two manually assembled oxygenators are used for experimental 
evaluation. The blood samples, outdated packed cells, are sourced 
from the Welsh Blood Service [24] which is accredited by the 
Medicines and Healthcare products Regulatory Agency [7] . The ex- 
periments are conducted by Haemair Ltd. and follow their stan- 
dard of operation procedure SOP2007v04. One of the prototypes is 
depicted in Fig. 1 . The core of the oxygenator is built with folded 
mats of hollow ﬁbres produced by Membrana GmbH [17] . The ﬁ- 
bres are state of the art (‘OXYPLUS ®’) and have an outer diameter 
of approximately 380 μm and a nominal wall thickness of 90 μm. 
The ﬁbre wall is highly porous ( ≥ 55%) to allow molecular diffusion 
but blocking any ﬂuid. For more details see Membrana GmbH [17] . 
Resin seals both ends of the oxygenator around the ﬁbres, forcing 
the blood to ﬂow between inlet and outlet ( Fig. 1 ). Ambient air is 
pumped through the hollow core of the ﬁbres. The nominal outer 
dimensions of the enclosure is 10 × 20 × 100 mm. Both prototypes 
are built to support ﬂow along the ﬁbres and to prevent cross- 
ﬂow between the ﬁbres at the same time, to minimize clotting 
and haemolysis. Additionally a virtual idealised geometry is used 
to set up the CFD model. Size, volume and ﬁbre count are com- 
parable to the real world devices. The ﬁbres in the virtual device 
are uniformly arranged to exploit symmetry and simplify meshing. 
The virtual model is used for comparison and to test the numerical 
solution. For all devices the key characteristics are listed in Table 1 . 
2.2. Reconstructed geometry 
μCT scans were performed on both prototypes using a Nikon 
XT H 225 with a voxel size of 22 μm. The source voltage and cur- 
rent were set to 55 kV and 174 μA, respectively. The exposure time 
for each radiograph was 2 s, with 720 radiographs being collected 
over 360 °. 
A complete set of reconstructed two-dimensional images was 
computed with ∼1500 ×10 0 0 pixels and a displacement in z - 
direction of ∼30 μm. The images captured from the μCT scan show 
the ﬁbres and their arrangement in great detail (see Fig. 2 ). The 
warp thread in OXYPLUS ® mats is a polyethylene terephthalate 
(PET) multiﬁlament yarn (33 dtex 1 ) with 24 ﬁlaments. The threads, 
with an estimated diameter of ∼70 μm ± 10, are woven into the ﬁ- 
bre bundle every 10 mm to keep the ﬁbres at a minimum distance 
and hence allow blood ﬂow in-between. Due to the small size of 
the threads, we assumed that any pressure drop or mixing affects 
can be neglected for this study. To verify that the ﬁbres remain 
in a straight line (in z -direction, see Fig. 4 ) throughout the device 
a visual inspection was conducted on a 3D compilation [22] of the 
μCT images (see Fig. 2 ) as well as overlaying 2 images from the op- 
posite ends. A cross-section image for each oxygenator ( Fig. 3 a and 
b) was used to recreate a full size real world three-dimensional 
geometry to run CFD-simulations. Both prototypes were manually 
1 Dtex (decitex) is a textile measuring unit for yarn. 1 dtex = 0.1 g/km. 
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Table 1 
Characteristics of oxygenators. 
Var Idealised SRD3078 SRD3083 
Width (mm) w 17.11 19.20 18.92 
Height (mm) h 8.63 9.87 9.70 
Length (mm) l 100 100 100 
Inlet/Outlet diameter (mm) 3 3 3 
Inlet/Outlet length (mm) 20 20 20 
Fibre wall thickness (μm) T f 90 90 90 ±10 μm 
Fibre outer diameter (μm) D fo 380 380 380 ±30 μm 
Fibre inner diameter (μm) D ﬁ 200 200 200 Nominal 
Fibre count ( n ) N f 512 508 531 
Fibres merged ( n (%)) 0 (0) 7 (1.4) 8 (1.5) 
Surface area ﬁbres (mm 2 ) A f 61,122.8 60,645.3 63,391.1 π × D f o × 10 −3 × l × N f 
Device volume (mm 3 ) V d 14,765.93 18,950.4 18,352.4 w × h × l
Fibre volume (mL) V f 5.8067 5.7613 6.0222 π × ( D f o 2 ) 2 × l × N f × 10 −9 
Static priming volume (mL) V b 8.9593 13.1891 12.3302 (V d × 10 −3 ) −V f 
Gas volume (mL) V g 1.6085 1.5959 1.6682 π × ( D f i 2 ) 2 × l × N f × 10 −9 
Blood volume oxygenated (mL) V b ∗ 0.6273 0.6224 0.6506 Eq. (4) , d = 10 μm 
Porosity (%)  60.68 69.60 67.19 V b 
V d ×10 −3 
V/Q ratio (%) 17.95 12.10 13.53 
V g 
V b 
V/Q ratio oxygenated (%) 256.41 256.41 256.41 
V g 
V b ∗
Fig. 2. Sliced 3D model reconstructed from μCT 2D images including a thread wo- 
ven in to maintain a minimum distance between the ﬁbres. 
assembled by folding HFM mats into the plastic enclosure. The 
device SRD3083 has added spacers (see Fig. 4 ) between the folds 
to support a uniform distribution of ﬁbres throughout the device. 
The spacers are 100 μm thick and are completely embedded in the 
resin sealed ends. 
2.3. Modelling technology and mesh dependency 
We use the cell centre based ﬁnite volume formulation to solve 
the incompressible Navier–Stokes equation for momentum and 
mass conservation. The blood ﬂow through the devices is modelled 
with ANSYS Inc. [1] —FLUENT. The solver was set for a pressure- 
based steady state solution with absolute velocity. The problem 
was discretised using a least-square cell based gradient formula- 
tion combined to a second order upwind discretisation scheme for 
momentum and a second order scheme for pressure. The SIMPLE 
algorithm was used for pressure coupling. A representative section 
of ﬁbres from the device SRD3078 was used to build a smaller ver- 
sion of blood oxygenator with a manually reﬁned mesh with ap- 
proximately 2 million elements. A grid convergence study was con- 
ducted to ﬁnd a suitable set of parameters to create an appropriate 
unstructured mesh for all devices. With a minimum size restric- 
tion for elements set to 1 × 10 −6 m and a biased sweep mesh for 
the main body, we have a conﬁdence level of ±2% error in regards 
to pressure drop for the numerical solution. To limit the amount 
of elements further, a minimum gap size of  10 μm is imposed 
between individual ﬁbres or between ﬁbres and enclosure. This 
is achieved by merging ﬁbres or joining ﬁbres with the enclosure 
wall if the gap is smaller (see Fig. 5 ). A total of 7 ﬁbres are merged 
for the device SRD3078 and 8 ﬁbres for the device SRD3083. For 
all meshes a minimum of ﬁve elements is enforced between the 
ﬁbres. All three geometries have a ﬁnal unstructured mesh with 
∼20 million cells. The inlet and outlet ( φ 3 mm) tube length is set 
to 20 mm to support a fully developed ﬂuid ﬂow entering the oxy- 
genator. The outlet is conﬁgured as pressure outlet and is set to 
0 Pa and the ﬁbres and the enclosure are deﬁned as no-slip walls. 
2.4. Simulation and visualisation of blood ﬂow 
A study comparing three rheological models (Casson, Ree- 
Eyring and Quemada [15] ) concluded that the Quemada model 
ﬁtted most precisely with their experimental ﬁndings. To solve 
the blood ﬂow as incompressible Non-Newtonian ﬂuid, the model 
(Quemada [21] , Eq. (1) ) is implemented as a user deﬁned function 
Fig. 3. (a,b) μCT images of a cross-section for two manually assembled blood oxygenator prototypes. (b) Spacers between the folds help to create a more uniform distribution 
of ﬁbres. (c) Idealised CFD-geometry to provide a comparable device with uniformly distributed ﬁbres. 
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Fig. 4. (A) Reconstructed ﬁbre distribution for SRD3078. (B,E) Inlet/outlet tube for blood. (C) Representation of “mid plane cross-section” to extract results, see Fig. 7 . 
(D) “Spacers” inserted on both ends for the device SRD3083 to support a uniform distribution of ﬁbres (cf. Fig. 3 a and b). 
Fig. 5. Fibres joined together or merged with the enclosure where the gap size is 
< 10 μm. 
Table 2 
Quemada model coeﬃcents. 
μp 1.23 mPa s Blood plasma viscosity 
H ct 48 % Haematocrit 
k 0 3.96 Model constant for zero shear rate 
k ∞ 1.71 Model constant for inﬁnite shear rate 
˙ γc 5.0 Characteristic rate of rouleaux formation/degradation 
to report shear dependent viscosity. Parameters for deriving the 
viscosity μ are based on the work of Marcinkowska-Gapinska et al. 
[15] and listed in Table 2 . Shear strain rate, denoted as ˙ γ is ob- 
tained from the ﬂow ﬁeld and the density is set to 1050 kg m −3 for 
average whole blood. With the above, viscosity can be described 
as 
μ = μp 
(1 − 1 
2 
k Q ∗ H ct ) 2 
with k Q = 
k 0 + k ∞ 
√ 
˙ γ
˙ γc 
1 + 
√ 
˙ γ
˙ γc 
. (1) 
The boundary condition for the blood ﬂow is set as mass 
ﬂow rate to 8 . 75 × 10 −5 kg s −1 ( 5 mL min −1 ) and 6 . 65 × 10 −3 kg s −1 
( 380 mL min −1 ), respectively. Two ﬂow rates were chosen for mod- 
elling: the low Reynolds number regime was used as a laminar 
regime validation and a higher ﬂow rate was used for direct com- 
parison with experiments under conditions relevant to the devices’ 
usage. For both prototype oxygenators the ﬂow is simulated in 
both directions (reversing the inlet and outlet), with otherwise the 
Fig. 6. Comparing area versus mass ﬂow of blood for each device at the mid plane 
cross-section ( l /2). Coloured solid lines represent forward ﬂow, coloured dotted 
lines represent the [R]everse ﬂow. For the idealised geometry the two mass ﬂow 
rates (5 mL min 
−1 
and 380 mL min 
−1 
) are plotted in black with no reverse ﬂow, 
since the geometry is symmetrical. (For interpretation of the references to colour in 
this ﬁgure legend, the reader is referred to the web version of this article.) 
same boundary conditions and parameters applied. The idealised 
geometry is symmetrical, hence there is no need to calculate the 
reverse ﬂow for comparison. 
To visualise mass ﬂow versus area ( Fig. 7 ) an ANSYS plug-in 
‘MassFlowAreaRatio’ was developed to interrogate the results in- 
teractively. The plug-in is using the built-in API to Perl and the 
Power Syntax from CFX-Post (ANSYS CFX Reference Guide release 
14.5) and allows to set arbitrary numbers of cross-sections in any 
direction with a pre-deﬁned threshold for mass ﬂow. Each step of 
the integration may be saved and stacks of images can be auto- 
matically saved to create an animation (see supplementary videos 
online–10.1016/j.medengphy.2017.06.035 ). 
2.5. Oxygenator shunt fraction 
Perfusion mismatch or impaired lung function is usually calcu- 
lated using the Berggren Equation for shunt fraction ( Q s / Q t [2] ) to 
express the ratio of blood bypassing oxygenation ( Q s ) to the total 
cardiac output ( Q t ). In this study we use a similar approach to de- 
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Fig. 7. Snap-shot of simulated mass ﬂow (70%) at the mid-plane cross-section ( l /2) 
for SRD3078 (top), SRD3083 (middle), and the idealised geometry (bottom), for a 
ﬂow rate of 5 mL min 
−1 
(left) and 380 mL min 
−1 
(right), respectively. The colours 
are for a better visualisation only, and may not be compared between the differ- 
ent devices and ﬂow rates (see supplementary videos online—10.1016/j.medengphy. 
2017.06.035 ). (For interpretation of the references to colour in this ﬁgure legend, 
the reader is referred to the web version of this article.) 
ﬁne the Oxygenator Shunt Fraction O sf ( Eq. (2) ) as ratio of blood 
volume bypassing oxygenation. 
O s f = 1 −
V b ∗
V b 
(2) 
The blood being oxygenated is deﬁned as V b ∗ and is derived in 
Eq. (3) and rearranged in Eq. (4) . In essence it describes the vol- 
ume of annuli with thickness d around the ﬁbres. See Table 1 for 
parameters length ( l ), count of ﬁbres ( N f ) and priming volume V b . 
V b ∗ = l × N f × π ×
((
D f o 
2 
+ d 
)2 
−
(
D f o 
2 
)2 )
(3) 
= l × N f × π × d × (D f o + d) (4) 
Assuming that only blood within a distance of d = 10 μm to the 
outer ﬁbre wall is active in gas exchange (approximately the size 
of human capillaries), Eq. (2) is used to ﬁnd the ratio of blood not 
being exposed to the hollow ﬁbre membrane and hence bypassing 
the oxygenation. O sf is only valid for non-turbulent ﬂow regimes 
with a perfect ﬂow in longitudinal direction ( z ). 
2.6. Cross ﬂow ratio coeﬃcient 
The presented oxygenator prototypes have been built to support 
ﬂow along the ﬁbres to minimize clotting and haemolysis as well 
as to study ﬂow rate and residence time. The goal is a perfect ﬂow 
in longitudinal direction z (parallel to the ﬁbres) in order to re- 
duce priming volume and minimise residence time with complete 
oxygen saturation of the blood. Due to an asymmetrical arrange- 
ment of inlet and outlet, as well as a deviation from a uniform 
ﬁbre distribution in the prototypes, we propose to use the coef- 
ﬁcient O cf ( Eq. (5) ) to quantify the amount of cross-ﬂow present. 
u i , v i , w i [ ms −1 ] are the three-dimensional components of the ve- 
locity vector at grid element i with count of all elements denoted 
by n . O cf is dimensionless and describes the mean deviation from 
longitudinal ﬂow-direction ( z ). 
O c f = 
1 
n 
n ∑ 
i =1 
√ 
u 2 
i 
+ v 2 
i √ 
u 2 
i 
+ v 2 
i 
+ w 2 
i 
(5) 
3. Results 
As shown in Figs. 2 and 3 , the images reconstructed from the 
μCT scan represent the oxygenator and the individual ﬁbres in 
great detail. This allows to rebuild an accurate three-dimensional 
geometry with a CAD software which subsequently can be used 
to set up a CFD model. A visual inspection of two cross-section 
images from opposite ends and of slices of the 3D reconstruction 
shows very little deviation of the ﬁbres in longitudinal direction 
( z ). The spacers built into SRD3083 increase the uniformity of the 
ﬁbre distribution signiﬁcantly. 
A two-dimensional cross-section plane is deﬁned at position l /2 
and for each cell in the mesh, mass ﬂow and area are extracted 
and plotted (see Fig. 6 ). A formal description is found in Eq. (6) . If 
Q bc is the prescribed mass ﬂow rate through the device and A CS is 
the cross-sectional area of the oxygenator then an area A can be 
deﬁned for every value of the ﬂow fraction Q , where the ﬂow 
fraction is deﬁned as 0 ≤ Q ≤ 1. 
A (Q ) = ˆ  x, ˆ  y : Q(x, y ) = Q ×Q bc ∧ ˆ x, ˆ  y ⊆ x, y , ∀ x, y ∈ A CS (6) 
The full data set for the cross-section is shown in Fig. 6 ( A , 
Q ) with A = A (Q ) A CS . Note that the graph is a reﬂection on how 
uniformly the ﬂow is distributed across the cross-section of the 
oxygenator. This is illustrated by a snap-shot of mass ﬂow to area 
ratio at 70% in Fig. 7 . The simulations show that large ﬂow chan- 
nels absorb most of the ﬂow. For the device SRD3078 70% mass 
ﬂow goes through only 10% area of the cross-section whereas the 
uniform arrangement of ﬁbres in the idealised geometry yields a 
much more even mass ﬂow versus area ratio. It can be further seen 
that the distribution of the ﬁbres within the device has little im- 
pact on the ﬂow directionality as mass ﬂow versus area remain the 
same. Figs. 6 and 7 highlight the impact of a non-uniform distribu- 
tion of ﬁbres within the oxygenator. 
The pressure drop however is ﬂow rate and direction depen- 
dent. Eight experiments on three different builds of this proto- 
type model are conducted. With an average ﬂow rate of 380 mL 
min −1 a mean pressure drop of 3792 Pa is measured. The computa- 
tional model for SRD3078 shows good agreement with 4053 Pa and 
3853 Pa [R]everse. As these devices have all been manually assem- 
bled, they have potentially large ﬂow channels as shown in Fig. 7 . 
SRD3083 (with spacers) has a calculated pressure drop of 6443 Pa 
and 6218 Pa [R] and the idealised geometry 10,186 Pa. The pressure 
drop for 5 mL min −1 varies between 40 Pa and 220 Pa, but there is 
no experimental data available to compare with. 
Cross-ﬂow coeﬃcients ( O cf ) for all devices and ﬂow rates 
are depicted in Fig. 8 . Results are extracted at 14 cross-sections 
throughout the main body of the oxygenators at locations corre- 
sponding to the mesh elements. Increased cross-ﬂow activity is 
visible close to inlet and outlet and is dependent on ﬂow rate and 
ﬁbre distribution. Due to a grid reﬁnement at the inlet/outlet Eq. 
(5) is bound to overestimate O cf and needs to be accounted for. The 
data suggest that decreasing the uniformity of ﬁbres (SRD3078) 
leads to ﬂow direction dependency whereas a uniform ﬁbre dis- 
tribution has the same O cf in both directions. 
With Eq. (2) and setting d = 10 μm (representative of the size of 
capillaries in the human lung) we can calculate the shunt fraction 
O sf for each device (see Table 3 ). The physical layout of the devices 
support ﬂow parallel to the ﬁbres, but as shown in Fig. 8 cross- 
ﬂow is present. A parameter to adjust O sf should be imposed to 
account for the cross-ﬂow; otherwise Eq. (2) is overestimating the 
dead space. We propose to use O cf as a relaxation factor for the 
shunt fraction O sf ( Eq. (7) ). 
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Fig. 8. O cf calculated at cross-sections corresponding to the mesh elements in z -direction. 
Table 3 
Shunt fractions independent of ( O sf ) and dependent on ( O s f ∗ ) q (ﬂow rate). 
q = 5 mL min −1 q = 380 mL min −1 
Device V b V b ∗ O sf O cf O s f ∗ O cf O s f ∗
SRD3078 13.1891 0.6224 0.9528 0.4520 0.5221 0.3815 0.5893 
SRD3078 [R] 13.1891 0.6224 0.9528 0.4493 0.5247 0.3979 0.5737 
SRD3083 12.3302 0.6506 0.9472 0.2278 0.7314 0.2221 0.7369 
SRD3083 [R] 12.3302 0.6506 0.9472 0.2273 0.7319 0.2207 0.7382 
Idealised 8.9593 0.6273 0.9300 0.1627 0.7787 0.1722 0.7698 
Table 4 
Streamline ( S l ) in seconds and standard residence ( τ ) time in seconds for ﬂow rate q . 
q = 5 mL min −1 q = 380 mL min −1 
Device S l min S l max S l med τ S l min S l max S l med τ
SRD3078 18.83 283.50 41.21 158.27 0.25 0.42 0.34 2.08 
SRD3078 [R] 19.89 30.76 24.43 158.27 0.34 0.46 0.39 2.08 
SRD3083 31.09 111.57 78.36 147.96 0.42 1.48 1.15 1.95 
SRD3083 [R] 35.71 119.66 89.16 147.96 0.64 1.55 1.19 1.95 
Idealised 70.74 86.68 78.99 107.51 0.85 1.08 0.97 1.41 
O s f ∗ = 1 −
V b ∗ + 
(
O c f ∗ (V b −V b ∗ ) 
)
V b 
(7) 
Thus we can account for a device dependent ﬂow behaviour occur- 
ring from different ﬁbre arrangements as well as for different ﬂow 
rates. Table 3 lists the improved shunt fractions. The lower limit 
of O s f ∗ is V b whereas the upper limit is deﬁned by V b ∗ . The blood 
volume around the ﬁbres being oxygenated, V b ∗ , is adjusted by the 
distance d (see Eq. (2) ) and needs to be chosen such that V b ∗ ≤ V b . 
Residence time of blood within the oxygenator was calculated 
in two ways; (i) by extracting streamlines ( S l ) from the numer- 
ical solution and (ii) by the generic equation for residence time 
τ = V/q with V = V b and q = Q d , set to the corresponding ﬂow rate. 
The standard residence time is valid for steady laminar ﬂow only. 
Reynolds number extracted for the numeric models are R e < 1 
for 5 mL min −1 ﬂow rate and R e < 80 for 380 mL min −1 hence 
ﬂow can be assumed laminar. Streamlines were extracted in the 
main body of the oxygenator starting from 10 0 0 equally spaced 
seed points. For the results in Table 4 only the streamlines reach- 
ing the outlet ( n > 95 % for all data sets) are considered. Fig. 9 a and 
b depicts the streamline time distribution for two different ﬂow 
rates. For better visualisation, only data points ≤ S l med (median) 
are plotted. The bin size for 5 mL min −1 ﬂow rate is 1 s and for 
380 mL min −1 0.01 s. Standard residence time in seconds (s) for 5 
mL min −1 is calculated with τ = (V b × 60) / 5 and for 380 mL min −1 
with τ = (V b × 60) / 380 . The results are listed in Table 4 . 
4. Discussion 
The presented μCT scans provide a feasible way to reconstruct 
an HFM-oxygenator with computer-aided design software (CAD) 
based on individual hollow ﬁbres. The geometry can subsequently 
be used to run CFD models to study relevant design parameters 
for blood oxygenators. As an example our model shows the in- 
sensitivity of ﬂow direction in regards to mass ﬂow versus area 
but highlights the importance of a uniform ﬁbre distribution. In 
the case of SRD3078 70% of blood is ﬂowing through the device 
with very little contact to ﬁbres, suggesting limited oxygenation ef- 
ﬁciency ( Fig. 7 ). By comparing pressure drops and residence times 
we can highlight the dependency on ﬂow direction. 
Especially residence time of blood is an important factor in the 
design of a blood oxygenator, to provide optimal mass transfer and 
blood oxygen saturation. We have shown that residence time based 
on velocity vectors (streamlines) in a full scale model reveal a dis- 
tribution which cannot be represented by the standard equation 
for ﬂuid resident time in a reservoir ( Table 4 and Fig. 9 ). Accord- 
ing to Kang et al. [12] the time of oxygen saturation of red blood 
cells is between 60 ms (rest) and 120 ms (exercise). This time scale 
is at least a magnitude shorter than the minimum residence time 
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Fig. 9. Distribution of streamline residence time in the main body of the oxygenator. For a better visualisation the graph depicts only data ≤ the median. (a) has a bin size 
of 1 s and (b) has a bin size of 0.01 s. 
of blood in the studied oxygenator. Hence our results suggest that 
even with a signiﬁcantly reduced length of the main body of the 
oxygenator suﬃcient oxygenation and a potential decrease of the 
device’s thrombogenicity could be achieved. 
Furthermore we have presented a method to quantitatively as- 
sess cross-ﬂow activity and a device dependent shunt fraction. De- 
spite the prototypes physically supporting longitudinal ﬂow, we 
could reveal cross-ﬂow activity probably due to the positioning of 
the blood inlet and outlet tube and a non-uniform distribution of 
ﬁbres. Oxygenator shunt fraction, O s f ∗ , takes ﬂow rate, direction 
and cross-ﬂow activity into account and can be adjusted using a 
single parameter d to describe the blood volume being oxygenated. 
We have used a nominal value of d = 10 μm to reﬂect human cap- 
illaries, but this may be different for other hollow ﬁbre membrane 
oxygenators and needs further investigation. Combined they show 
the potential as a qualitative design optimization parameter. 
So far, to the best of our knowledge, the existing literature re- 
ports studies with a porous zone or a uniformly distributed ar- 
rangement of ﬁbres to model the blood ﬂow through the oxygena- 
tor. Using either method assumes a homogeneous uniform perme- 
ability or a pre-calculated permeability based on a uniform distri- 
bution of ﬁbres. In this study, we have shown that such a distri- 
bution of ﬁbres is unlikely and even a small variability in gap size 
between the ﬁbres changes the ﬂow behaviour signiﬁcantly. 
5. Conclusions 
μCT scans provide a feasible tool to rebuild the geometry of a 
hollow ﬁbre membrane oxygenator. We have shown how to quan- 
titatively and qualitatively assess prototype oxygenators and can 
conclude that a signiﬁcant change in transport phenomena and 
mass exchange is to be expected if large gaps between ﬁbres are 
present, i.e. uniform distribution of ﬁbres are paramount for blood 
oxygenators. 
To solve a full scale meshed oxygenator is computationally 
more expensive than a porous media approach, but yields an in- 
sight into the oxygenator otherwise not achievable. We were able 
to solve the ﬂow problem on the model presented ( ∼20 million 
cells) within 24 h on a single workstation computer (Xeon E3-1240 
v3, 4 cores at 3.4 GHz, 16 GB RAM). 
We have shown the capability of using a full scale three- 
dimensional numerical model to realistically simulate ﬂow be- 
haviour using accurate geometrical descriptions of the oxygenator 
rather than idealised geometries. As the boundaries of the ﬁbres 
are accurately meshed, further analysis of mass transfer is possi- 
ble by solving a convection-diffusion problem based on the ﬂow 
solutions in this work. The reconstruction of individual ﬁbres for 
example, could be used to apply the transport models presented 
by Taskin et al. [23] to calculate individual P O 2 proﬁles and study 
the mass exchange in detail. Such a model is therefore a feasible 
tool to study design optimisations of HFM oxygenators and may 
facilitate the development of a wearable ECMO device and/or an 
implantable artiﬁcial lung. 
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